ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
A synthetic trachea based on a composite of POSS and PCU—polyhedral oligomeric silsesquioxane and poly(carbonate-urea) urethane—has been transplanted into a cancer patient. According to Hybrid Plastics, supplier of the POSS, the patient’s body accepted the synthetic trachea because it was seeded with the patient’s own stem cells. The Hattiesburg, Miss.-based firm says the composite, developed by University College London Medical School professor Alexander M. Seifalian, could also be used to form human arteries, veins, heart valves, or tear ducts.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X